Tesamorelin

Tesamorelin — Growth Hormone Releasing Factor (GHRF) Analog

Tesamorelin is a synthetic peptide analog of growth hormone-releasing factor (GHRF), developed for research focused on endocrine signaling and hormone regulation. It is designed to stimulate the release of endogenous growth hormone through interaction with receptors in the pituitary, making it a valuable compound for studying pathways related to metabolic function and hormonal balance.

Mechanism of Action

Tesamorelin acts by binding to growth hormone-releasing hormone (GHRH) receptors located in the anterior pituitary. This interaction initiates a signaling cascade that promotes the natural release of growth hormone, which can then influence downstream processes such as insulin-like growth factor-1 (IGF-1) activity.

In research models, Tesamorelin has been associated with modulation of lipid metabolism, endocrine signaling, and cellular growth pathways. Its structure allows for enhanced stability and receptor specificity, making it suitable for studying sustained hormonal responses and regulatory feedback mechanisms within the endocrine system.

Research Applications

• Growth hormone and IGF-1 pathway studies
• Endocrine system signaling and regulation research
• Lipid metabolism and metabolic function models
• Hormonal feedback loop investigations
• Cellular growth and protein synthesis pathways
• Long-acting GHRH analog research

Product Specifications

• Quantity: 10 mg per vial (adjust based on your SKU)
• Purity: ≥99% (HPLC verified)
• Form: Lyophilized powder
• Storage: Refrigerate after reconstitution
• Testing: Third-party lab tested in the USA, COA available